SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-045671
Filing Date
2024-11-14
Accepted
2024-11-14 14:19:05
Documents
58
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 985743
2 ex10-5.htm EX-10.5 309422
3 ex10-6.htm EX-10.6 46661
4 ex10-7.htm EX-10.7 25464
5 ex10-8.htm EX-10.8 29916
6 ex10-9.htm EX-10.9 25274
7 ex10-10.htm EX-10.10 25399
8 ex10-11.htm EX-10.11 27142
9 ex10-12.htm EX-10.12 25170
10 ex10-13.htm EX-10.13 22134
11 ex10-14.htm EX-10.14 22192
12 ex10-15.htm EX-10.15 23693
13 ex31-1.htm EX-31.1 12069
14 ex31-2.htm EX-31.2 12611
15 ex32-1.htm EX-32.1 6047
16 ex32-2.htm EX-32.2 6643
  Complete submission text file 0001493152-24-045671.txt   5756385

Data Files

Seq Description Document Type Size
17 XBRL SCHEMA FILE kapa-20240930.xsd EX-101.SCH 39276
18 XBRL CALCULATION FILE kapa-20240930_cal.xml EX-101.CAL 30107
19 XBRL DEFINITION FILE kapa-20240930_def.xml EX-101.DEF 205641
20 XBRL LABEL FILE kapa-20240930_lab.xml EX-101.LAB 394231
21 XBRL PRESENTATION FILE kapa-20240930_pre.xml EX-101.PRE 297651
60 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 586044
Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Filer) CIK: 0001962011 (see all company filings)

IRS No.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42275 | Film No.: 241460326
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)